dilluns, 20 d’octubre del 2014

Boston Scientific launches stent trial for underserved demographics




Boston Scientific launches a clinical trial examining outcomes in underserved populations with its Promus Premier drug-eluting stent.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1tFntbk

Cap comentari:

Publica un comentari a l'entrada